Biopsy Devices Market Research Explores Growth Within A $4.94 Billion Opportunity

The biopsy devices market is set to experience substantial growth in the coming years, driven by technological advancements and rising demand for precise diagnostic tools. As healthcare shifts toward more accurate and minimally invasive procedures, this sector is positioned for significant expansion. Let's explore the market size projections, key players, emerging trends, and detailed segmentation shaping the biopsy devices industry.

Forecasted Market Size and Growth Drivers in the Biopsy Devices Market
The biopsy devices market is projected to reach a valuation of $4.95 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.8%. Several factors contribute to this growth, including the increased adoption of AI-assisted biopsy guidance systems, growing preference for outpatient diagnostic procedures, and the broader implementation of precision oncology. Moreover, heightened emphasis on early disease detection and rising investments in advanced biopsy technologies are further propelling market expansion. Key trends anticipated to influence this market include the widespread use of image-guided biopsy systems, a shift toward minimally invasive biopsy techniques, growing demand for devices enabling precision sampling, automation in biopsy guidance, and a strong focus on improving diagnostic accuracy.

Download a free sample of the biopsy devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Factors Encouraging Growth in the Biopsy Devices Sector
One of the primary forces behind the market's growth is the integration of artificial intelligence to enhance biopsy guidance, which improves procedural outcomes and diagnostic precision. This technological leap supports clinicians in acquiring more accurate tissue samples, reducing errors, and optimizing patient care.
Additionally, an expanding emphasis on outpatient procedures is driving demand, as healthcare providers seek less invasive and more efficient diagnostic methods. This trend is closely linked to the rise of personalized medicine and precision oncology, where accurate biopsy sampling plays a critical role in tailoring treatments to individual patient profiles.

Leading Organizations Driving Innovation in the Biopsy Devices Industry
The biopsy devices market features several prominent companies, including Becton dic*kinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical LLC, Argon Medical Devices Inc, Olympus Corporation, Medtronic plc, Stryker Corporation, B Braun Melsungen AG, INRAD Inc, TSK Laboratory, Mauna Kea Technologies, Veran Medical Technologies, Merit Medical Systems Inc, ConMed Corporation, DTR Medical, Gallini Srl, TransMed7 LLC, MDL Srl, and Biopsybell Srl.
A notable development in this space was in June 2023, when US-based Quest Diagnostics acquired Haystack Oncology. Quest Diagnostics plans to incorporate Haystack's innovative minimal-residual disease (MRD) testing technology, which analyzes circulating tumor DNA (ctDNA), into new blood-based clinical laboratory services for solid tumors. These services are expected to launch in 2024, representing a significant step forward in cancer diagnostics.

View the full biopsy devices market report:
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Creating Opportunities in the Biopsy Devices Market
Top players in this market are focusing on refining fine-needle biopsy precision technologies to boost both sample quality and diagnostic accuracy. These advancements involve the use of specialized needle tips and enhanced materials designed to preserve cell architecture during tissue extraction, which is vital for reliable pathology results.
For example, in October 2025, Japan-based Olympus introduced its SecureFlex single-use fine-needle biopsy device. Constructed with nitinol and featuring a dual-beveled Raptor Tip, this device allows for larger, intact tissue samples by minimizing tissue loss and enhancing puncture efficiency. Its multi-layer sheath design facilitates consistent access to challenging anatomical regions such as the pancreatic head and uncinate process without repeatedly adjusting the scope. SecureFlex is intended for use in endoscopic ultrasound-guided fine-needle biopsies (EUS-FNB) of gastrointestinal lesions, improving sample quality, procedural safety, and efficiency.

Detailed Market Segmentation of the Biopsy Devices Industry
This report breaks down the biopsy devices market into various segments:
1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, and Other Products
2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, and Other Imaging Technologies
3) By Application Area: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, and Other Applications
4) By End User: Diagnostics and Imaging Centers, Hospitals, and Other End Users

Further subdivisions include:
- Needle-Based Biopsy Guns: Spring-Loaded and Vacuum-Assisted Guns
- Biopsy Forceps: Endoscopic and Surgical Forceps
- Biopsy Guidance Systems: Ultrasound-Guided, CT-Guided, and MRI-Guided Systems
- Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, and Coaxial Needles
- Other Products: Biopsy Sutures, Biopsy Markers, and Biopsy Storage Solutions

This comprehensive segmentation highlights the diverse range of products and applications that drive the biopsy devices market forward.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.